Invesco
IMNM icon

Invesco’s Immunome IMNM Stock Holding History

Invesco’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
68,938
+2,373
+4% +$50.8K ﹤0.01% 2726
2026
Q1 		$1.46M Sell
66,565
-203,500
-75% -$4.53M ﹤0.01% 2697
2025
Q4 		$5.8M Buy
270,065
+214,049
+382% +$3.76M ﹤0.01% 2172
2025
Q3 		$656K Buy
56,016
+27,224
+95% +$271K ﹤0.01% 3120
2025
Q2 		$268K Buy
28,792
+413
+1% +$3.39K ﹤0.01% 3412
2025
Q1 		$191K Buy
28,379
+1,718
+6% +$16.5K ﹤0.01% 3522
2024
Q4 		$283K Sell
26,661
-406,059
-94% -$4.91M ﹤0.01% 3429
2024
Q3 		$6.33M Buy
432,720
+406,783
+1,568% +$5.78M ﹤0.01% 2092
2024
Q2 		$314K Sell
25,937
-599,146
-96% -$9.37M ﹤0.01% 3477
2024
Q1 		$15.4M Buy
+625,083
New +$12.7M ﹤0.01% 1578

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Invesco's IMNM Position: Q2 2026 in Review

Invesco increased its Immunome (IMNM) stake by 3.6% in Q2 2026, buying an estimated $50.8K and bringing the position to 68,938 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

Invesco first reported a position in IMNM in Q1 2024 and has held it in 10 quarters since. The position peaked at $15.4M in Q1 2024. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Invesco held 68,938 shares of Immunome worth $1.46M as of Q2 2026.
  • Invesco bought 2,373 Immunome shares in Q2 2026, an estimated $50.8K.
  • Immunome made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2726 holding.
  • Invesco first reported a position in Immunome in Q1 2024 and has held it in 10 quarters since.
  • Invesco's Immunome position peaked at $15.4M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.